Roberto Scatena
Istituto Chimica e Chimica Clinica
Università Cattolica del Sacro Cuore
Largo Francesco Vito 1
00168 Rome
Italy
Name/email consistency: high
- Nitroflurbiprofen (NicOx). Scatena, R. Curr. Opin. Investig. Drugs (2004)
- O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier. Scatena, R., Giardina, B. Expert. Opin. Biol. Ther (2001)
- Bivalirudin: a new generation antithrombotic drug. Scatena, R. Expert. Opin. Investig. Drugs (2000)
- Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases. Scatena, R. Expert. Opin. Investig. Drugs (2000)
- Bezafibrate as differentiating factor of human myeloid leukemia cells. Scatena, R., Nocca, G., Sole, P.D., Rumi, C., Puggioni, P., Remiddi, F., Bottoni, P., Ficarra, S., Giardina, B. Cell Death Differ. (1999)
- Bucindolol (Bristol-Myers Squibb Co). Scatena, R. IDrugs (1999)
- Impaired reactive oxygen metabolism of phagocytic leukocytes in NIDDM patients. A role for non-enzymatic glycosylation of collagen. Scatena, R., Nocca, G., De Sole, P., Bottoni, P., Giardina, B. J. Biolumin. Chemilumin. (1998)